Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.

about

Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.

Item

http://www.wikidata.org/entity/Q55041037

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Evaluation of drug interaction ...... e doses in healthy Caucasians.

@en

Evaluation of drug interaction ...... e doses in healthy Caucasians.

@nl

type

Item

label

Evaluation of drug interaction ...... e doses in healthy Caucasians.

@en

Evaluation of drug interaction ...... e doses in healthy Caucasians.

@nl

prefLabel

Evaluation of drug interaction ...... e doses in healthy Caucasians.

@en

Evaluation of drug interaction ...... e doses in healthy Caucasians.

@nl

P1476

Evaluation of drug interaction ...... e doses in healthy Caucasians.

@en

P2093

Jieon Lee

http://www.w3.org/2001/XMLSchema#string

Kyung-Sang Yu

http://www.w3.org/2001/XMLSchema#string

SeungHwan Lee

http://www.w3.org/2001/XMLSchema#string

Su-Jin Rhee

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis

Rational approaches to the treatment of hypertension: drug therapy-monotherapy, combination, or fixed-dose combination?

Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status

Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.

Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction

Rosuvastatin calcium in acute coronary syndromes.

Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers.

P304

787-794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S145339

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29670335

http://www.w3.org/2001/XMLSchema#string

P932

5896677

http://www.w3.org/2001/XMLSchema#string